Stockwinners Market Radar for February 28, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:34 EDT Altice USA discloses purchase of 7M shares of common stock sold by investors - After the market closed today, funds advised by BC Partners and Canada Pension Plan Investment Board elected to sell 34M Altice USA Class A shares, representing approximately one third of their stake in the company. Consistent with Altice USA's share repurchase program and guidance for repurchases during 2019, the company elected to purchase approximately 7M of these shares for a total consideration of $150M. Following these transactions, BCP and CPPIB together own approximately 10.5% of Altice USA.

20:05 EDT Eclipse Resources, Blue Ridge Mountain Resources close strategic combination - Eclipse Resources Corporation (ECR) and Blue Ridge Mountain Resources (BRMR) announce they have completed the transaction to combine the two companies under the definitive merger agreement, which was previously approved by the boards of directors and stockholders of each company. The Company is also announcing that it has entered into an amended and restated credit agreement to expand its borrowing base from $225 million to $375 million and extended the maturity date to 2024. In conjunction with the closing, the Company changed its name to Montage Resources Corporation and effected the previously announced 15-to-1 reverse stock split of its common stock. The Company's common stock will begin trading on the New York Stock Exchange under the new symbol "MR" on March 1, 2019, giving effect to the reverse stock split. As previously disclosed, Blue Ridge stockholders will receive consideration consisting of 4.4259 shares of Eclipse Resources common stock for each share of Blue Ridge common stock before adjustment for the reverse stock split, or 0.29506 shares of Eclipse Resources common stock for each share of Blue Ridge common stock after adjustment for the reverse stock split.

19:03 EDT Fly Intel: After Hours Movers - UP AFTER EARNINGS: The Gap (GPS) up 23.6% after Q4 earnings, spin-off of Old Navy... Puma Biotech (PBYI) up 21.5%... Zscaler (ZS) up 14.1%... Habit Restaurants (HABT) Up 14.0%... Funko (FNKO) up 12.4%... Axa Equitable (EQH) up 9.8%... Bio-Rad Labs (BIO) up 7.1%... AMC Entertainment (AMC) up 6.8%... Radius Health (RDUS) up 5.8%... CymaBay Therapeutics (CBAY) up 4.9%... 3D Systems (DDD) up 4.7%... comScore (SCOR) up 4.3%... CarGurus (CARG) up 3.9%... Farfetch (FTCH) up 3.7%... Rigel Pharma (RIGL) up 3.2%... VMWare (VMW) up 3.0%... Splunk (SPLK) up 2.7%... Southwestern Energy (SWN) up 2.1%... Autodesk (ADSK) up 1.5%... Dell Technologies (DELL) up 1.3%... Ritchies Bros (RBA) up 1.3%... Workday (WDAY) up 1.2%... Nordstrom (JWN) up 0.8%. DOWN AFTER EARNINGS: Nutanix (NTNX) down 22.1%... Maxar Tech (MAXR) down 16.6%... Intrexon Corp (XON) down 9.7%... Tactile Systems (TCMD) down 7.9%... Alarm Holdings (ALRM) down 7.8%... TPI Composites (TPIC) down 6.6%... Stericycle (SRCL) down 6.6%... Castlight Health (CSLT) down 6.0%... Pure Storage (PSTG) down 5.3%... Kratos Defense (KTOS) down 5.2%... Neophotonics (NPTN) down 4.8%... Zix Corp (ZIXI) down 4.8%... Tabula Rasa Healthcare (TRHC) down 2.0%... Nektar Therapeutics (NKTR) down 1.3%. ALSO LOWER: Tesla (TSLA) down 3.5% after launch of $35K Model 3. Movers as of 18:45ET.

18:42 EDT Nomad Foods CEO: 'We have prepared all the contingencies for Brexit' - In an interview on CNBC's Mad Money, Nomad Foods CEO Stefan Descheemaeker said: "40% of our business is fish, 20% is vegetable... Millennials are similar in Europe... We are a category leader in Europe... We have great brands and pricing power... We have prepared all the contingencies for Brexit."

18:29 EDT Medley Capital stockholders requests investigation into stockholder meeting - Medley Capital (MCC) was issued a demand by an investment vehicle affiliated with NexPoint Advisors to make its books and records available for inspection. The investment vehicle, Highland Select Equity Master Fund, owner of common stock of MCC, seeks to investigate potential wrongdoing in the adjournment of the special meeting of stockholders, originally scheduled for February 8. This includes, among other things, the decision to amend company bylaws on February 6, which Select Fund believes improperly enabled the adjournment, which may not have passed a stockholder vote. The agenda for the February 8 Meeting included a shareholder vote on a merger with affiliate Sierra Income. Both Sierra and MCC are controlled, directly or indirectly, by Medley Management, (MDLY). According to the company, the Government Shutdown hindered the review and/or approval of documentation required to close the mergers, but not to hold the February 8 Meeting. The vote of a majority of stockholders would have been required to adjourn the February 8 Meeting. Select Fund believes the decision to adjourn the February 8 Meeting and the February 6 Amendment, was carried out in the interest of MDLY and its stockholders to the detriment of stockholders of MCC, because of the likelihood of a vote against the MCC Merger were the meeting to proceed as scheduled.

18:11 EDT Acceleron treatment of Charcot-Marie-Tooth disease gets FDA orphan designation - In a post on the FDA's website, Acceleron's treatment of Charcot-Marie-Tooth disease, efmitermant alfa, received FDA orphan designation. Reference Link

18:05 EDT Lockheed Martin awarded $108.74M Navy contract delivery order - Lockheed Martin has been awarded $108.74M for cost-plus-fixed-fee delivery order against a previously issued basic ordering agreement. This order provides for program management, nonrecurring engineering, recurring engineering, site support and touch labor in support of modification and retrofit activities for delivered Air Systems for the F-35 Lightning II Joint Strike Fighter aircraft for the Air Force, Marine Corps, Navy, non-Department of Defense, or DoD, participant and Foreign Military Sales, or FMS, customers. Work will be performed in Fort Worth, Texas and is expected to be completed in February 2020. FY17 and FY19 aircraft procurement: FY17, FY18 and FY19 aircraft procurement; FY19 aircraft procurement; non-DoD participant and FMS funds in the amount of $108.74M will be obligated at time of award, $8.36M of which will expire at the end of the current fiscal year. This order combines purchases for the Air Force; Marine Corps; Navy; non DoD Participants and FMS customers. The Naval Air Systems Command is the contracting activity.

18:01 EDT Northrop Grumman awarded $117.37M Navy procurement contract modification - Northrop Grumman has been awarded $117.37M for modification to a previously awarded fixed-price-incentive-firm contract. This modification exercises an option to procure 145 D2 Processors, 434 D2 Antenna Detectors; 253 D2 Radar Receivers; 107 D2 Low Band Arrays; 211 D2 Battery Handle Assemblies; 8 D2 Digital Receiver Processor Circuit Card Assemblies, or CCAs; 10 D2 Radio Frequency Distribution CCAs; 10 D2 Dual Down Converter CCAs; 14 D2 Quad Receiver Exciter CCAs; 6 D2 Low Voltage Power Supply CCAs; 53 C2 Processors; 160 C2 Antenna Detectors; 132 C2 Radar Receivers; 89 C2 input/output Processor CCAs; 89 C2 Signal Processor Unit CCAs; 7 Advanced Main Processor Unit CCAs; 7 C2 Digital Yttrium Iron Garnet, or YIG, Interface CCAs; 7 C2 Analog YIG Interface CCAs and 5 C2 Upgrade Kits. In addition, this option exercise includes technical engineering, logistics and management services to fabricate, assemble, test and deliver AN/APR-39 C/D2 systems and associated hardware in support of Navy, Army, Air Force and Foreign Military Sales. Work is expected to be completed in August 2021. FY17, FY18 and FY19 aircraft procurement; FY19 aircraft procurement; working capital and FMS funds in the amount of $117.37M will be obligated at time of award, $33.24M of which will expire at the end of the current fiscal year. This option combines purchase for the Navy, Army, FMS and Air Force. The Naval Air Systems is the contracting activity.

18:01 EDT Great Panther Silver sees 2019 production 3.7 to 4.0 million Ag eq oz. - Cash cost per silver ounce guidance for 2019 is $5.00 to $6.50 and the AISC guidance range is $13.00 to $15.00. Expects 2019 CapEx $1.5M-$1.9M. Great Panther expects to close the Acquisition of Beadell in early March. On January 29, 2019, Beadell issued 2019 production guidance of 145,000 to 155,000 gold ounces at an all-in sustaining cost of $1,000 to $1,100 per ounce. A planned increase in the processing capacity from the Topia Mine in 2019 is expected to increase Topia's production by approximately 25% compared to 2018.

17:55 EDT Boeing awarded $428.9M Navy acquisition contract modification - Boeing has been awarded a $428.9M advanced acquisition contract modification to a previously awarded firm-fixed-price contract. This modification provides for long-lead material and activities in support of 16 P-8A lot 11 aircraft to include six for the Navy, four for the government of New Zealand and six for the Republic of Korea. Work will be performed in Seattle, Washington; Huntington Beach, California and various locations within the continental U. S. and is expected to be completed in June 2020. FY19 aircraft procurement and foreign military sales funds in the amount of $428.9M will be obligated at time of award, none of which will expire at the end of the current fiscal year. This modification combines purchases for the Navy, the Republic of Korea and the government of New Zealand under the FMS program. The Naval Air Systems Command is the contracting activity.

17:50 EDT Meta Financial provides information about allegations from one lessee - Meta Financial Group is providing information about a specific situation involving a single relationship in the company's solar leasing business given recent allegations of fraud and other wrong doing by one lessee and its affiliates. Meta previously purchased a portfolio of mobile solar generators from DC Solar Solutions, Inc. and certain of its affiliates and, in turn, leased the generators to DC Solar Distribution, Inc., another affiliate of DC Solar Solutions. Recently, the Company became aware that the DC Solar entities named above, and their affiliates, filed for Chapter 11 bankruptcy protection and that they, along with their principals, are subjects of an ongoing federal investigation involving allegations of fraudulent conduct. The company believes this was an isolated, non-credit-related event involving a single third-party seller and lessee of mobile solar generators. Meta continues to gather information about the situation and is undertaking a full inventory of its leased generators. Currently, the timing of and extent to which the Company will be able to recover the related assets remain uncertain. As of January 31, 2019, the net book value of the assets leased to DC Solar Distribution totaled $13.7 million. In addition, Meta previously recognized $7.9 million of investment tax credits associated with such assets between fiscal year 2017 and 2018. At this time, the Company is unable to determine the financial impact to the Company, if any, or the amount of previously recorded tax credits that may be recaptured. "Strong asset quality is a high priority for Meta. We believe the fundamentals of our company remain sound and this isolated situation does not represent declining credit standards or deterioration within any particular sector," said President and CEO Brad Hanson. "The majority of our other leased alternative energy assets are not mobile, but rather deployed in fixed locations with power purchase agreements to support payment of lease obligations and are performing as expected. Our due diligence process involves verification and registration stages, as well as independent valuation practices. Nevertheless, we will continue to evaluate our diligence processes. We expect to continue capitalizing on opportunities that meet our rigorous underwriting and return criteria to maximize shareholder returns."

17:45 EDT General Dynamics awarded $1.36B Army contract for Stryker logistics services - General Dynamics was awarded a $1.36B cost-plus-incentive-fee contract for Stryker wholesale supply, performance-based, logistics services. Bids were solicited via the internet with one received. Work locations and funding will be determined with each order, with an estimated completion date of February 28, 2024. U.S. Army Contracting Command is the contracting activity.

17:41 EDT Tesla resumes trade down over 3% at $310 per share

17:40 EDT Tesla trading resumes

17:37 EDT VMware says Q4 was a terrific quarter - VMware (VMW) says achieved synergy goal with Dell Technologies (DELL). Says buzz about 5G is at an all-time high. Says booked largest vSAN deal in Q4. Says deals are starting to get larger. Says will focus more on cloud. Says solutions are core for customers in the future. Comments taken from Q4 earnings conference call.

17:30 EDT Tesla confirms availability of $35K Model 3, shifting all sales online - The company states: "We are incredibly excited to announce that the standard Model 3, with 220 miles of range, a top speed of 130 mph and 0-60 mph acceleration of 5.6 seconds is now available at $35,000! Although lower in cost, it is built to achieve the same perfect 5-star safety rating as the longer-ranged version, which has the lowest probability of injury of any car ever tested by the U.S. Government. In addition, we are introducing the Model 3 Standard Range Plus, which offers 240 miles of range, a top speed of 140 mph, 0-60 mph acceleration of just 5.3 seconds and most premium interior features at $37,000 before incentives. For 6% more money, you get 9% more range, more power, and an upgraded interior. To achieve these prices while remaining financially sustainable, Tesla is shifting sales worldwide to online only. You can now buy a Tesla in North America via your phone in about 1 minute, and that capability will soon be extended worldwide. We are also making it much easier to try out and return a Tesla, so that a test drive prior to purchase isn't needed. You can now return a car within 7 days or 1,000 miles for a full refund. Quite literally, you could buy a Tesla, drive several hundred miles for a weekend road trip with friends and then return it for free. With the highest consumer satisfaction score of any car on the road, we are confident you will want to keep your Model 3. Shifting all sales online, combined with other ongoing cost efficiencies, will enable us to lower all vehicle prices by about 6% on average, allowing us to achieve the $35,000 Model 3 price point earlier than we expected. Over the next few months, we will be winding down many of our stores, with a small number of stores in high-traffic locations remaining as galleries, showcases and Tesla information centers. The important thing for customers in the United States to understand is that, with online sales, anyone in any state can quickly and easily buy a Tesla. At the same time, we will be increasing our investment in the Tesla service system, with the goal of same-day, if not same-hour service, and with most service done by us coming to you, rather than you coming to us. Moreover, we guarantee service availability anywhere in any countries in which we operate. We're also excited to announce that we're implementing a number of firmware upgrades for both new and existing customers. These upgrades will increase the range of the Long Range Rear-Wheel Drive Model 3 to 325 miles, increase the top speed of Model 3 Performance to 162 mph, and add an average of approximately 5% peak power to all Model 3 vehicles. Tesla is committed to making not just the best electric cars, but the best cars, period. And our products are the reason we continue to rank #1 in Consumer Reports owner satisfaction survey and have every single year since Tesla was first eligible to be included in 2013. Both Model 3 Standard and Standard Plus are available starting today at Tesla.com.Reference Link

17:14 EDT Construction Partners announces two acquisitions in Florida - Construction Partners announced that it has completed two acquisitions in Florida for the aggregate purchase price of approximately $19M, paid entirely from cash on hand. CPI expects to make customary capital improvements for both acquired businesses but does not anticipate these expenditures to be material. CPI acquired a liquid asphalt terminal located in Panama City, Florida. CPI currently anticipates that the terminal will primarily service its own plants, with minimal third-party sales. CPI also acquired a hot mix asphalt and ready-mixed concrete business located in Okeechobee, Florida. This transaction enables CPI to serve new markets in south central Florida through an expanded geographic presence in the state.

17:01 EDT Hilton increases stock repurchase authorization by $1.5B - The board of Hilton has authorized the repurchase of an additional $1.5B of common stock under the company's existing stock repurchase program, bringing the total amount currently authorized for repurchase to approximately $1.9B.

16:54 EDT Youngevity's Khrysos Industries closes on 45-acre tract of land in Florida - Youngevity's wholly-owned subsidiary, Khrysos Industries, has closed on a 45-acre tract of land in Central Florida. The company intends to erect two separate, already contracted, pre-fabricated 2,800-square-foot buildings on the land. One will be dedicated as a revenue center focused on toll processing utilizing Khrysos' new continuous flow post processing system. The system also includes decarboxylation and filtration. The second building will be dedicated to hemp genetic research with the aim at increasing specific yields of certain cannabinoids. Additionally, the company has leased an 8,800 square foot facility in Central Florida that will serve as the assembly, manufacturing, and production facility for Khrysos' one-ton Hyper Supercritical extraction systems.

16:53 EDT Autodesk sees FY20 total ARR up 27%-29% - Sees FY20 billings up 50%-53%.

16:51 EDT Commercial Vehicle Group launches strategic reorganization into two segments - Commercial Vehicle Group announced a strategic reorganization of its operations into two business segments, Electrical Systems and Global Seating. The Electrical Systems segment will be comprised of the wire harness, interior trim, wipers, and structures businesses. Richard Tajer, who recently joined CVG to assume the role of Senior Vice President and Managing Director of the Global Wire Harness business, will drive the execution of its growth strategy in wire harness and adjacent electrical markets. Prior to joining CVG, Tajer spent 20 years with Yazaki North America. Global Seating will maintain strong historical brands and the company expects the segment to be better positioned to take advantage of growth in geographies such as China and India. Doug Bowen will assume responsibility for the Global Seating segment as Senior Vice President and Managing Director. Bowen most recently served as Senior Vice President and Managing Director for CVG's GCAM segment.

16:49 EDT Funko sees FY19 adjusted EBITDA $133M-$143M vs. $116.2M last year

16:48 EDT Leidos awarded $85.5M follow-on contract by NGA - Leidos has been awarded an $85.5M follow-on contract by the National Geospatial Intelligence Agency to provide sustainment and adaptive maintenance for nine NGA mission applications. The single award, cost-plus-fixed-fee contract has a one-year base followed by four option years. Work will be performed in Gaithersburg, Md., Alexandria, Va., and Tucson, Az.

16:47 EDT Emergent BioSolutions awarded Department of State contract - Emergent BioSolutions announced that it has signed an indefinite-delivery, indefinite-quantity contract with the U.S. Department of State to establish a long-term, reliable, and stable supply chain for medical countermeasures that address chemical warfare agents. The contract is comprised of a five-year base period of performance along with five one-year option periods with a total contract value of a minimum of approximately $7M to a maximum of $100M over the contract's period of performance. Emergent will be supplying two of its current medical countermeasures addressing chemical threats; the Trobigard atropine sulfate/obidoxime chloride auto-injector, a drug-device combination product for emergency use in the event of nerve agent or organophosphate poisoning, and RSDL, which is intended to remove or neutralize chemical warfare agents and T-2 toxin from the skin.

16:46 EDT Duke Energy appoints Marya Rose as board member - Duke Energy's (DUK) board of directors announced the appointment of Marya Rose, chief administrative officer at Cummins (CMI) as a new board member, effective March 1.

16:45 EDT MDU Resources: Knife River acquires additional aggregate deposits in Texas - MDU Resources announced that subsidiary Knife River Corporation has acquired substantial additional aggregate deposits in Texas, which will augment existing company operations and enhance its ability to sell aggregates to third parties. The 570 acres of land near Marble Falls, Texas, were purchased from Capitol Aggregates Inc. Financial details of the acquisition were not disclosed.

16:41 EDT Agree Realty appoints David A. Wolff as Chief Accounting Officer - Agree Realty has appointed David Wolff joined the company as its Chief Accounting Officer. Wolff most recently, he served as Vice-President, Financial Reporting & Chief Accounting Officer of The Taubman Company .

16:40 EDT Esperion sees 2019 net cash used in operations $25M-$35M - Esperion expects 2019 net cash used in operations to be $25M-$35M. Esperion expects that current cash resources, coupled with expected milestone payments under the European commercial collaboration agreement, as well as bempedoic acid and the bempedoic acid / ezetimibe combination tablet commercial sales, are sufficient to fund operations until operating cash flow is positive. Upcoming milestones include: enrollment completion in the CLEAR Outcomes study in Q3 and top-line results from the 12-week, Phase 2 study of the bempedoic acid / ezetimibe combination tablet in patients with elevated LDL-C and type 2 diabetes mellitus and pivotal phase 3 trial initiation of bempedoic acid in patients with elevated LDL-C and type 2 diabetes, to support a glycemic control indication in adults with type 2 diabetes mellitus as well as HbA1c data inclusion in the second half 2019.

16:37 EDT Marriott sees North America RevPAR up 1%-2% in Q1 - "We expect North America RevPAR will increase 1 to 2 percent in the first quarter, reflecting the impact of the government shutdown offset by a favorable calendar comparison. Outside North America, RevPAR growth is expected to moderate slightly in the first quarter due to the slower economic growth outlook in the Asia Pacific region. For the full year 2019, we expect North America and worldwide RevPAR growth of 1 to 3 percent and rooms growth of roughly 5.5 percent, net. This should yield an increase in total fee revenue of 5 to 7 percent, despite foreign exchange headwinds. It should also enable us to return at least $3 billion to shareholders in share repurchases and dividends in 2019, even assuming no asset sales for the year."

16:36 EDT AXA Equitable raises quarterly dividend by 15% to 15c per share effective Q2 - AXA Equitable declared quarterly dividend of 13c per share payable on March 15 and the company intends to increase the dividend by 15% to 15c per share in the second quarter.

16:34 EDT AXA Equitable announces new $800M stock buyback

16:33 EDT Corporacion America Airport chairman Eduardo Eurnekian resigns - Corporacion America Airport announced that Eduardo Eurnekian submitted his resignation as board chairman and board member of the company on February 26, effective immediately. Eduardo Eurnekian, founder of Corporacion America Group, will continue with his other business ventures as well as philanthropic activities. Maximo Bomchil, a current director, has been appointed board chairman of Corporacion America Airports effective immediately. The noard has also appointed Daniel Marx as new member of the board of the company also effective immediately.

16:31 EDT Edison International says 2018 performance negatively impacted by wildfires - "Edison International's performance in 2018 was negatively impacted by wildfires in our service territory and a charge for liabilities related to the Southern California wildfires and mudslides. Devastating wildfires have become a regular occurrence in California and mitigating this threat continues to be our top priority. We are working closely with State, county and municipal leaders, as well as the business community, to develop responsible, regional and statewide solutions to address the ongoing wildfire risk. SCE has proposed multiple programs to enhance operational practices and increase grid hardening which we have already started implementing. In addition, we continue to make substantial investments to support California's climate change policies. All of these illustrate California's need for financially healthy utilities and therefore the need for sustainable wildfire risk management policies," said Pedro Pizarro, president and CEO of Edison International.

16:29 EDT Spectrum sees 2019 SG&A costs down 30% vs. 2018 - The company states: "Assuming the previously announced divestiture transaction closes in March, we expect 2019 SG&A costs to decrease by approximately 30% relative to 2018. We expect 2019 R&D costs to increase nominally as reduced spending on the legacy assets is offset by the increased spending on pre-commercial supply and tech transfer activities for ROLONTIS and poziotinib. With the increase of cash from the sale of our commercial assets, we expect our cash balance to be sufficient to fund operations for at least three years."

16:27 EDT Nektar says working closely with FDA on NDA for NKTR-181 - Nektar CEO Howard Robin said in tonight's earnings release, "2018 was a remarkable year for Nektar accentuated by new collaborations with leading pharmaceutical companies that validate the depth and innovation of our pipeline. We entered 2019 in an exceptionally strong financial position. We are working closely with the FDA during the ongoing review of our NDA for NKTR-181 while simultaneously preparing for a potential commercial launch later this year. We continue to design and execute on our broad registrational program for NKTR-214 (bempegaldesleukin1) with our partner Bristol-Myers Squibb. NKTR-358 is advancing in the ongoing clinical study in lupus patients and two new studies in additional auto-immune conditions are planned to start in 2019. NKTR-262, our TLR agonist is being evaluated in a Phase 1/2 study and finally, NKTR-255, our next I-O candidate is slated to move into the clinic first in patients with multiple myeloma and then in combination with CAR-T therapy."

16:25 EDT RLJ Lodging Trust reports Q4 adjusted EBITDA $113.8M vs. $136.5M last year - Reports Q4 occupancy 73.7% vs. 76.2% last year.

16:23 EDT Lantronix CEO Jeff Benck resigns - Lantronix (LTRX) announced that Jeff Benck has resigned from his role as president and CEO and as a director of Lantronix effective March 8, to pursue another opportunity as the CEO of Benchmark Electronics (BHE). Lantronix CFO Jeremy Whitaker will serve as interim CEO of the company until the board appoints a new permanent CEO.

16:20 EDT Meta Financial provides information on events concerning lessee - Meta Financial Group is providing information about a specific situation involving a single relationship in the company's solar leasing business given recent allegations of fraud and other wrong doing by one lessee and its affiliates. Meta previously purchased a portfolio of mobile solar generators from DC Solar Solutions and certain of its affiliates and, in turn, leased the generators to DC Solar Distribution, another affiliate of DC Solar Solutions. Recently, the company became aware that the DC Solar entities named above, and their affiliates, filed for Chapter 11 bankruptcy protection and that they, along with their principals, are subjects of an ongoing federal investigation involving allegations of fraudulent conduct. The company believes this was an isolated, non-credit-related event involving a single third-party seller and lessee of mobile solar generators. Meta continues to gather information about the situation and is undertaking a full inventory of its leased generators. Currently, the timing of and extent to which the company will be able to recover the related assets remain uncertain. As of January 31, the net book value of the assets leased to DC Solar Distribution totaled $13.7M. In addition, Meta previously recognized $7.9M of investment tax credits associated with such assets between FY17 and FY18. At this time, the company is unable to determine the financial impact to the company, if any, or the amount of previously recorded tax credits that may be recaptured.

16:17 EDT Financial Institutions increases quarterly dividend 4.2% - Financial Institutions announced that its board has approved a quarterly cash dividend of 25c per outstanding common share, which represents a 4.2% increase from the most recent quarterly cash dividend. Dividends are payable April 2 to shareholders of record on March 15.

16:16 EDT Gap announces plan to separate Old Navy into standalone company

16:14 EDT Farfetch sees FY19 platform GMV up 40% - The company expects to continue to make investments to grow the business, including for its recent acquisitions, while also leveraging costs, and estimates full year 2019 Adjusted EBITDA margin of approximately (18%) - (19%), prior to any benefit from the adoption of IFRS 16.

16:14 EDT Jagged Peak Energy sees FY19 average daily production 38.3-41.3 MBoe/d - Sees FY19 average daily oil production 29.2-31.2 MBbl/d. Sees FY19 CapEx $605M-$665M.

16:12 EDT Jagged Peak Energy sees Q1 average daily equivalent production 36.5-37.9 MBoe/d - Sees Q1 average daily oil production 27.5-28.9 MBbl/d.

16:09 EDT SpartanNash increases quarterly dividend 1c to 19c per share - SpartanNash announced that its board has approved an increase to its quarterly cash dividend from 18c to 19c per common share. The dividend will be paid on March 29 to shareholders of record as of March 15.

16:08 EDT Workday up 3.6% after reporting Q4 earnings, giving FY20 guidance

16:04 EDT Nutanix reports Q2 billings $413.4M vs. $355.9M last year

16:02 EDT Kratos Defense acquires Florida Turbine Technologies - Kratos Defense & Security Solutions announced that it has acquired an 80.1% interest in Florida Turbine Technologies and FTT Core, for $60M, consisting of $33M in cash and $27M in Kratos common stock. Kratos has an option to acquire the remaining 19.9% of FTT at a future date. FTT, which is forecasting revenues and adjusted EBITDA of approximately $45M and $4.5M, respectively, for the 10 month period March 1 through December 31, 2019, will now be part of the Kratos Turbine Technologies Division, which will be focused on the development and production of small, affordable, high-performance, jet engines for the next generation of tactical weapon systems and tactical jet unmanned aerial systems.

15:57 EDT North American Energy trading resumes

15:44 EDT North American Energy trading halted, news pending

15:39 EDT Tesla says 'The wait is almost over, great things are coming at 2pm' on website - Reference Link

15:13 EDT Comfort Systems USA Chairman Franklin Myers purchases $211K in shares - Comfort Systems USA Chairman Franklin Myers disclosed in a filing that he had purchased 4,000 shares of company stock at an average price of $52.84 per share on February 27. The total transaction value was $211,348.

14:53 EDT Devon Energy director Robert Henry buys $350K in company shares - Devon Energy director Robert Henry disclosed in a filing that he had sold 11,651 shares of company stock at an average price of $30.01 per share on February 27. The total transaction value of the sale was $349,647.

14:03 EDT Immucell submits manufacturing technical section for its purified Nisin product - ImmuCell announced a critical milestone in the development of Re-Tain, its Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. The company has made its first phased submission to the U.S. Food and Drug Administration of the manufacturing technical section with respect to the Nisin Drug Substance under the company's New Animal Drug Application. This submission is subject to a six-month review period and will be followed by a second phased submission covering the Nisin Drug Product, which is also subject to a six-month review period before anticipated product approval can occur. This is the fifth of five major Technical Sections required for NADA approval by the FDA and product launch. ImmuCell has previously received four Technical Section Complete Letters from the FDA, most recently for the Human Food Safety Technical Section during the third quarter of 2018. Also, the FDA recently approved "Re-Tain" as the Company's tradename for the anticipated commercial product. "This is a huge milestone for ImmuCell and for our team that has worked so hard over the past years to develop and optimize the manufacturing process and to design, construct and qualify our new Drug Substance facility," commented Elizabeth L. Williams, Vice President of Manufacturing Operations. "The capstone was the recent manufacture and analysis of Registration Batches bridging back to the pivotal batches used in key studies. Our team has persisted through the many stages of development and has consistently demonstrated the needed tenacity, creativity and energy to reach this milestone. I am honored to work with them."

13:19 EDT FTC announces settlement with AbbVie over Solvay's AndroGel - The Federal Trade Commission said it has reached a settlement in the case alleging that the brand-name drug company Solvay and three generic drug companies "illegally" agreed to restrict generic competition to Solvay's branded testosterone-replacement drug AndroGel for nine years. Under the settlement, Solvay's current owner AbbVie is prohibited from entering into certain patent infringement settlement agreements that restrict generic entry for certain drugs and contain common forms of reverse payments, the FTC announced. The settlement exempts licenses to enter the market on a later date, compensation for saved future litigation costs up to $7M, a continuation or renewal of a pre-existing agreement, and "several other types of agreements that are unlikely to be anticompetitive," according to the agency. The order, if approved by the court, will remain in effect for 10 years. Reference Link

13:10 EDT Southwest rallies amid rumor of Warren Buffett takeover interest - Shares of Southwest Airlines (LUV) jumped this morning as a takeover rumor surfaced on social media. The conjecture seemed to originate from a Twitter account run by StockTradersNET, which tweeted earlier today, "$LUV talk Berkshire Hathaway seeking to acquire remaining shares of Southwest (NYSE: LUV) $75/shr unconfirmed." In a response to the rumor, Southwest told Bloomberg, "There has been speculation circulating that Warren Buffett might be looking to acquire an airline for some time and that Southwest might be a good fit. As a policy, we do not comment on speculation, but appreciate Berkshire's continued support of Southwest Airlines." Berkshire, which also owns stakes in American Airlines (AAL), Delta Air Lines (DAL) and United Continental (UAL), is the second-biggest shareholder in Southwest, with a 9.9% holding, according to Bloomberg. Shares of Southwest are up 4%, or $1.98, to $55.83 in afternoon trading.

12:19 EDT Take-Two up 3% as company appears to skip Morgan Stanley conference - Shares of Take-Two Interactive are up 3% in early afternoon trading amid signs that the company cancelled out of a planned investor event. On January 31, the company had announced in a press release that CEO Strauss Zelnick planned to present at the Morgan Stanley Technology, Media & Telecom Conference in San Francisco. The company's presentation had been scheduled for Thursday, February 28, at 8:55 a.m. Pacific Time. Take-Two also stated that a link to the live webcast of the presentation was to be available via the company's website. However, the site for the conference, and Take-Two's investor relation site, do not include any link to or mention of the company presenting today. Near 12:20 ET, or 9:20 PT, shares of Take-Two are up $2.63, or 3.1%, to $87.26. Reference Link

12:06 EDT Baidu launches AI home theater system and Xiaodu Smart Display 1S assistant - Baidu launched two new AI-based IoT smart devices for the Chinese market - Xiaodu TV Mate, an innovative 3-in-1 smart device with integrated functions of a home theater system, 4K high definition set-top box, and smart speaker, and Xiaodu Smart Display 1S, a smart speaker with extensive content library and upgraded 'Kid's Mode'.

12:02 EDT Bristol-Myers 'confident' in combination with Celgene, will respond to Starboard - Bristol-Myers Squibb (BMY) issued the following statement in response to a letter from Starboard Value: "Bristol-Myers Squibb welcomes the opinions of all of its stockholders and will review Starboard's letter and respond in due course. The Bristol-Myers Squibb Board and management team are confident that our combination with Celgene Corporation (CELG) will create a premier biopharma company and deliver substantial benefits to our stockholders. This combination is consistent with our strategy and is the natural next step in the evolution of Bristol-Myers Squibb. As a combined entity, we will enhance our leadership positions across our portfolio, including in oncology, immunology and inflammation and cardiovascular. We will also benefit from an expanded early- and late-stage pipeline highlighted by six expected near-term product launches, including five from Celgene, representing more than $15 billion in total revenue potential. Together, our pipeline holds significant promise for patients, allowing us to accelerate new options through a broader range of cutting-edge technologies and discovery platforms."

12:00 EDT HP Inc. falls -16.2% - HP Inc. is down -16.2%, or -$3.87 to $19.98.

12:00 EDT Gray Television rises 12.6% - Gray Television is up 12.6%, or $2.37 to $21.18.

12:00 EDT Triple-S rises 26.1% - Triple-S is up 26.1%, or $5.61 to $27.12.

11:37 EDT Genentech announces FDA approval for Herceptin Hylecta in HER2-positive BCs - Genentech, a member of the Roche Group, announced the U.S. Food and Drug Administration has approved Herceptin Hylecta for subcutaneous injection for the treatment of certain people with HER2-positive early breast cancer in combination with chemotherapy and HER2-positive metastatic breast cancer in combination with paclitaxel or alone in people who have received one or more chemotherapy regimens for metastatic disease. This new treatment includes the same monoclonal antibody as intravenous Herceptin in combination with recombinant human hyaluronidase PH20, an enzyme that helps to deliver trastuzumab under the skin. Herceptin Hylecta is a ready-to-use formulation that can be administered in two to five minutes, compared to 30 to 90 minutes for intravenous Herceptin. The FDA approval is based on results from three clinical studies in HER2-positive early breast cancer: The Phase III HannaH study compared neoadjuvant and adjuvant Herceptin Hylecta to intravenous Herceptin, both in combination with chemotherapy. Subcutaneous administration of Herceptin Hylecta resulted in non-inferior levels of trastuzumab in the blood and non-inferior clinical efficacy. The Phase III SafeHER study of adjuvant Herceptin Hylecta identified no new safety signals, with safety and tolerability consistent with the known safety profiles of intravenous Herceptin and Herceptin Hylecta. The PrefHER patient preference study of adjuvant Herceptin Hylecta followed by intravenous Herceptin, or the reverse sequence, found the majority (86 percent) of people preferred Herceptin Hylecta over intravenous Herceptin.

11:01 EDT Quaker Chemical opens new plant in Dahej, India - Quaker Chemical opened its new state-of-the-art manufacturing facility in Dahej, India. The site will be used to produce rolling oils and metalworking fluids for the steel and metalworking market in India, the Middle-East, and east Africa. The Dahej facility will add between 7,000 and 12,000 metric tons of capacity to the company's operations by the end of 2019, with plans to increase that capacity to 20,000 metric tons over the next few years.

10:02 EDT Apellis announces collaboration with SFJ Pharmaceuticals for APL-2 - Apellis Pharmaceuticals (APLS) announced a novel, risk-sharing collaboration to support the development of APL-2 in hematologic indications with SFJ Pharmaceuticals, a global drug development company backed by Blackstone Life Sciences (BX) and Abingworth. As part of this collaboration, SFJ and Apellis have entered into an agreement to support the development of APL-2 for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Under the terms of the agreement, SFJ has agreed to pay Apellis $60M in support of the PNH clinical program following deal close, with up to an additional $60M based on Apellis meeting specific, pre-defined clinical milestones that are expected in 2019 and associated with the PNH development program, and subject to Apellis meeting certain capital requirements. Subject to mutual agreement, SFJ may also pay Apellis an additional $50M in funding for the PNH clinical program following a specified, pre-defined clinical milestone. In addition, Apellis and SFJ have entered into a letter of intent to negotiate and enter into a joint development agreement to support Apellis' clinical development programs for APL-2 for the treatment of patients with cold agglutinin disease and warm antibody hemolytic anemia. Following execution of the CAD/wAIHA joint development agreement, including agreed upon development plans, Apellis would receive up to $30M in funding. Subject to mutual agreement, SFJ may also pay Apellis an additional $50M in funding for the CAD and wAIHA clinical programs following a specified, pre-defined clinical milestone. Together the PNH agreement and the CAD/wAIHA agreement would provide the potential for up to $250M in non-dilutive financing. Under the terms of the PNH agreement, Apellis will pay SFJ regulatory approval milestone payments in annual increments at a pre-determined payment schedule over six years, with the majority of payments to SFJ due in years 3-6 following regulatory approval. No approval payments are owed to SFJ should regulatory approval not be achieved for PNH. Apellis has an option to buy-out of all or part of the milestone payments at any time following regulatory approval at a discounted rate. Apellis will retain exclusive worldwide commercial rights to APL-2 in all indications.

10:00 EDT Fitbit falls -16.9% - Fitbit is down -16.9%, or -$1.16 to $5.71.

10:00 EDT Eros Now announces integration deal with Virgin Media in the U.K. - Eros Now announced an integration deal with the world's largest international TV and broadband company, Virgin Media. The integration deal will provide Virgin TV customers in the United Kingdom direct access to Eros Now's massive library of 12,000 films, original web-series, music and short-format content through Eros Now Quickie. The premium Indian OTT app will be available on Virgin TV connected boxes as part of its 'Desi Pack' with effect from February 28, 2019.

10:00 EDT Tutor Perini rises 12.1% - Tutor Perini is up 12.1%, or $2.13 to $19.65.

10:00 EDT California Resources rises 19.6% - California Resources is up 19.6%, or $4.27 to $26.09.

09:53 EDT Horizon Pharma jumps after Phase 3 OPTIC trial meets endpoints - Shares of Horizon Pharma are up over 25% in early trading after the company reported earlier the topline results from its Phase 3 confirmatory trial evaluating teprotumumab for the treatment of active thyroid eye disease. The trial, titled OPTIC, met its primary endpoint, showing more patients treated with teprotumumab compared with placebo had a meaningful improvement in proptosis, or bulging of the eye: 82.9% of teprotumumab patients compared to 9.5% of placebo patients achieved the primary endpoint of a 2 mm or more reduction in proptosis, the main cause of morbidity in TED. All secondary endpoints were also met and the safety profile was consistent with the Phase 2 study of teprotumumab in TED, the company said. "The dramatic results of the teprotumumab Phase 3 confirmatory trial, in addition to positive Phase 2 data, form a highly convincing body of clinical evidence supporting teprotumumab for the treatment of active thyroid eye disease. This is a key milestone as we evolve into a research-focused company developing innovative new medicines to address challenging diseases with very few effective options. We are one step closer to delivering the first FDA-approved treatment to people living with active thyroid eye disease, and we are grateful to the patients, physicians and investigational sites who have partnered with Horizon to make the teprotumumab research and development program possible," said Timothy P. Walbert, chairman, president and CEO of Horizon Pharma. In morning trading, Horizon shares are up $5.60, or 25.6%, to $27.45.

09:47 EDT Target, vineyard vines announce limited-edition collaboration - Target and vineyard vines announced a limited-edition collaboration. The collection includes more than 300 unique items spanning home and outdoor goods, pets, as well as apparel, accessories and swim for the entire family. A number of items in the collection are a first for the vineyard vines brand, including many of the home and outdoor goods, such as tableware and games. Ranging in price from $2-$120, with most items under $35, the collection is designed to celebrate the ultimate summer gathering, where everyone's invited.

09:47 EDT HP Inc. falls -15.1% - HP Inc. is down -15.1%, or -$3.61 to $20.24.

09:47 EDT Rubicon Project rises 9.8% - Rubicon Project is up 9.8%, or 51c to $5.70.

09:47 EDT California Resources rises 17.1% - California Resources is up 17.1%, or $3.73 to $25.55.

09:41 EDT Celgene deal not in best interest of Bristol-Myers holders, Starboard says

09:32 EDT Nevada reports January statewide gaming win down 3.01% to $984.53M - Nevada's Gaming Control Board reports Las Vegas Strip gaming win was down 4.06% in January to $532.25M. Publicly traded companies in the casino gaming space include Boyd Gaming (BYD), Caesars (CZR), Las Vegas Sands (LVS), MGM Resorts (MGM), Penn National (PENN) and Wynn Resorts (WYNN).

09:24 EDT American Vanguard seeks to purchase product lines from Willowood USA - American Vanguard Corporation through its principal operating subsidiary, AMVAC, has entered into an agreement for the purchase of selected product lines and related inventory from Willowood USA, which has sought approval of the transaction with the U.S. Bankruptcy Court under Rule 363. AMVAC's bid is further subject to a potential bid process before the bankruptcy court and final approval by that court, which if granted, would occur by mid-April 2019. Bob Trogele, EVP & COO of AMVAC commented: "This potential acquisition includes more than a dozen herbicide technical registrations and nearly 2 dozen formulation registrations, which will enable us to develop new and improved premix solutions. We will provide additional details of this acquisition if approval is obtained from the bankruptcy court."

09:13 EDT Greenlight's Einhorn says Brighthouse was firm's 'biggest detractor' in Q4 - David Einhorn said on Greenlight Capital Re's (GLRE) earnings call that Brighthouse Financial (BHF) was the firm's biggest detractor in Q4. Says Ensco (ESV) was second biggest detractor in Q4, AerCap (AER) was third biggest detractor. Says had a "handful of winners" in short book in Q4. Says GM (GM) stands to further benefit from cost cutting program.

09:10 EDT Amazon announces 'Amazon Day' for prime members, a consolidated delivery day - Amazon is bringing a new level of delivery convenience and predictability to Prime members with the launch of Amazon Day, available today to all Prime members in the U.S. This new delivery innovation enables Prime members to choose a day of the week to be their delivery day, which makes it easier to get purchases grouped and delivered together and, in many cases, in fewer packages. Members can also choose from Prime's fast, free shipping options for any item they don't want to include as part of their Amazon Day shipment. The program is one of many sustainability initiatives to help achieve Shipment Zero, the company's vision to make all Amazon shipments net zero carbon, with 50% of all shipments net zero by 2030. Once Prime members select a day of the week that works best for them, adding items to their Amazon Day order is easy, with all items ordered that week arriving together on the designated day. Members can choose to use the Amazon Day delivery option any time they'd like and it's easy to change their Amazon Day at checkout to another day that works best for them. Prime members who enroll in Amazon Day can also take advantage of Prime's other fast, free delivery options by selecting the best option for each eligible item at checkout such as Prime FREE One-Day Shipping and Prime FREE Same-Day Delivery in more than 10,000 cities and towns, two-hour delivery with Prime Now in more than 30 major cities, and unlimited Free Two-Day Shipping on more than 100 million items.

09:08 EDT Comtech wins $1.5M award for military SATCOM TWTAs - Comtech Telecommunications announced that during it second quarter of fiscal 2019, its Santa Clara, California-based subsidiary, Comtech Xicom Technology, Inc., which is part of Comtech's Commercial Solutions segment, has received a contract for more than $1.5 million for Ku and Ka-band high-power traveling wave tube amplifiers, or TWTAs, for a transportable satellite communications ground system.

09:07 EDT Insperity raises quarterly dividend to 30c per share from 20c per share - Insperity announced that its board has approved a 50% increase in its quarterly regular cash dividend from 20c per share to 30c per share. The cash dividend will be paid on March 28, to all stockholders of record as of March 14.

09:05 EDT Michaels appoints Mark Cosby as interim CEO, succeeding Chuck Rubin - The Michaels Companies (MIK) announced the appointment of Mark Cosby as interim CEO and Board Member effective today. Mr. Cosby succeeds Chuck Rubin, who has mutually agreed with the Board of Directors to transition out of his role as CEO. Mr. Rubin will continue as Chairman of the Board of Directors until April 1, 2019. The Board has initiated a search to identify a permanent CEO. Cosby joins The Michaels Companies following a 30-year career at a number of leading retail chains, most recently serving as President, North America at Office Depot (ODP). The Company also announced that it has appointed Philo T. Pappas as Interim President - Merchandising and Supply Chain. Pappas has been with the Company since 2009, most recently serving as President - Michaels Stores Procurement Company and formerly serving as Executive Vice President - Merchandising.

09:03 EDT Synopsys enters $100M accelerated share repurchase agreement with Wells Fargo - Synopsys (SNPS)announced that it has entered into an accelerated share repurchase agreement with Wells Fargo Bank (WFC) to repurchase an aggregate of $100M of Synopsys stock. Under the terms of the ASR, Synopsys will receive an aggregate initial share delivery of approximately 780K shares, with the remainder, if any, to be settled on or before May 17, upon completion of the repurchases. The specific number of shares that Synopsys ultimately repurchases under the ASR will be based on Synopsys' volume-weighted average share price during the repurchase period, less a discount

09:02 EDT Bed Bath & Beyond signs multi-year contract extension with CommerceHub - Bed Bath & Beyond has signed an exclusive, multi-year extension to its agreement with CommerceHub, a distributed commerce network for retailers and brands. The company will expand their use of CommerceHub solutions meant to enable high-volume drop-ship fulfillment, efficient SKU builds and compliant content exchange with suppliers, shipping optimization and LTL fulfillment for large items.

08:52 EDT PG&E says recorded new $1B charge related to 2017 Northern CA wildfires

08:50 EDT PG&E says 'probable' equipment will be deemed cause of Camp Fire - PG&E said that "Although the cause of the 2018 Camp Fire is still under investigation, based on the information currently known to the company and reported to the California Public Utilities Commission and other agencies, the company believes it is probable that its equipment will be determined to be an ignition point of the 2018 Camp Fire."

08:48 EDT Nielsen says it needs to transform to a product driven company - Says it had solid finish to 2018. Says financials on track. Says improved operating discipline in FY18. Says cash flow exceeded expectations in the second half of the year. Says focused on transition to high performing company. Says needs faster, bolder decisions. Says will retire many legacy systems. Says company must do better. Sees FY19 free cash flow $525M-$575M. Comments and guidance taken from Q4 earnings conference call.

08:36 EDT MyoKardia sees cash funding operations into 2020 - Based on its current operating plans, MyoKardia anticipates that current cash, cash equivalents and investments are sufficient to fund operations into late 2020.

08:32 EDT Canopy Growth, Sequential Brands: Martha Stewart joins in advisory role - Canopy Growth (CGC) and Sequential Brands Group (SQBG) announced that Martha Stewart has joined the company in an advisory role to assist with developing and positioning a broad new line of product offerings across multiple categories. With several clinical trials underway, Canopy Growth will be leaning on Martha's vast knowledge of consumer products while exploring the effectiveness of CBD and other cannabinoids as they relate to improving the lives of both humans and animals. As previously reported in January 2019, Canopy Growth has developed diverse product offerings specific to hemp-derived CBD and the company looks forward to working closely with Martha Stewart as they further develop and introduce these products to market in the future. Canopy Growth previously reported that it will invest between $100M-$150M in a hemp industrial park in New York State with an intended purpose of being the company's first hemp facility in the United States.

08:23 EDT Tredegar CEO John Gottwald plans to retire, John Steitz to succeed - Tredegar announced that John Gottwald plans to retire as Tredegar's president and CEO. He will continue to serve as a member of Tredegar's board and its executive committee. Tredegar's board has elected John Steitz to succeed Gottwald as Tredegar's president and CEO. Steitz's election and Gottwald's retirement will be effective as of the day following the filing of the company's Annual Report on Form 10-K for the year ended December 31, 2018 with the SEC, which is expected to occur on March 18, 2019.

08:16 EDT Pfizer announces serotypes included in 20vPnC candidate - Pfizer announced today the new serotypes included in its 20-Valent pneumococcal conjugate vaccine candidate, PF-06482077, being investigated for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes covered in the vaccine in adults aged 18 years and older. Pfizer's 20vPnC candidate includes the 13 serotypes contained in Prevnar 13 plus 7 additional serotypes. Pfizer also announced that data from a Phase 2, proof-of-concept study of 20vPnC in adults have been accepted for oral presentation at the upcoming 29th European Congress of Clinical Microbiology and Infectious Diseases, which will take place in Amsterdam, Netherlands, from April 13-16, 2019. In addition, three Phase 3 trials have been initiated for the purpose of evaluating 20vPnC in adults. Combined, these three trials will enroll more than 6,000 adult subjects, including populations of vaccine-naive adults and adults with prior pneumococcal vaccination. All seven of the new serotypes included in 20vPnC are global causes of invasive pneumococcal disease, and six of the seven serotypes are associated with high case-fatality rates. In addition, four of these serotypes are associated with antibiotic resistance and/or meningitis. Together, all of the 20 serotypes included in 20vPnC are responsible for the majority of currently circulating pneumococcal disease in adults in the U.S. and globally

08:15 EDT Nordson CEO Michael Hilton to retire - Nordson announced that Michael Hilton plans to retire as President and CEO after nine successful years with the company. The board has initiated a search of internal and external candidates for his successor. Throughout this process, Hilton will remain in his current role as President and CEO to ensure a smooth transition.

08:11 EDT Churchill Downs subsidiary enters multi-year agreement with Spin Games - Spin Games announced that it has entered into a multi-year agreement with Churchill Downs Interactive Gaming, or CDIG, a subsidiary of Churchill Downs, to deploy Spin's interactive gaming content into CDIG's BetAmerica Sportsbook and Casino website and mobile apps. Following an integration to connect Spin's ROC remote gaming server, or RGS, platform with SBTech's gaming platform, Spin Games has deployed its interactive gaming content in the BetAmerica Sportsbook and Casino in New Jersey and, subject to regulatory approval, will go live in Pennsylvania this year.

08:09 EDT Sensus Healthcare names Dr. Ziv Karni as Chief Scientific Officer - Sensus Healthcare announced that the company has appointed Dr. Ziv Karni to the role of Chief Scientific Officer, effective immediately. Karni, a pioneer in medical technology research and development, has more than 30 years of experience in the development and sales of medical and aesthetic technologies. He will report to Joe Sardano, Sensus Healthcare CEO.

08:07 EDT Heico subsidiary acquires Decavo in all-cash deal, terms not disclosed - HEICO announced that its Flight Support Group acquired 80.1% of Decavo, LLC in an all cash transaction. HEICO stated that it expects the acquisition to be accretive to its earnings within the year following the purchase. Further financial terms and details were not disclosed.

08:05 EDT Marriott Vacations sees FY19 adjusted EBITDA $745M-$785M - Sees FY19 contract sales $1.53B-$1.6B; adjusted free cash flow $400M-$475M.

08:04 EDT TriMas increases share repurchase authorization to $75M - TriMas announced that its Board of Directors increased the Company's common stock share repurchase authorization to $75M. The previous authorization, approved in November 2015, authorized up to $50M in share repurchases. During the fourth quarter, the Company purchased 318,494 shares of its outstanding common stock for approximately $8.6M, bringing the total for the year ended December 31, 2018 to 442,632 shares, or approximately 1% of shares outstanding. The Company began repurchasing shares during the second quarter of 2018, and utilized $12.1M of the prior $50M authorization through 2018. The increased share repurchase authorization includes the value of shares already repurchased under the previous authorization.

07:58 EDT Novartis shareholders approve launch of share repurchase program up to CHF 10B - ovartis shareholders today agreed to the Board of Directors' recommendations for all proposed resolutions at the Group's Annual General Meeting. A total of 1,991 shareholders were present at the meeting held in Basel, representing approximately 65.6% of the issued shares of Novartis.. In line with the Board of Director's recommendation, shareholders also approved the cancelation of 23,250,000 shares repurchased under the seventh share repurchase program in 2018 and to reduce the share capital accordingly by CHF 11,625,000, from CHF 1,275,312,410 to CHF 1,263,687,410. Shareholders also approved the launch of an eighth share repurchase program up to a maximum of CHF 10B worth of shares until 2022.

07:56 EDT Edgewell Personal Care appoints Daniel J. Sullivan as CFO - Edgewell Personal Care has appointed Daniel J. Sullivan as CFO, effective April 1. He will succeed Rod Little, who was appointed President and CEO effective March 1. Sullivan most recently served as CFO of Party City, a publicly traded, global business, where he oversaw all aspects of finance, business development and investor relations and helped develop and execute the company's omni-channel growth and M&A strategies.

07:54 EDT Novartis shareholders approve 2% dividend increase to CHF 2.85 - Novartis shareholders agreed to the Board of Directors' recommendations for all proposed resolutions at the Group's Annual General Meeting total of 1,991 shareholders were present at the meeting held in Basel, representing approximately 65.6% of the issued shares of Novartis. Shareholders approved the 22(nd) consecutive dividend increase per share since the creation of Novartis in 1996, with an increase of 2% to CHF 2.85 for 2018. Payment for the 2018 dividend will be made as of March 6, 2019. The dividend for 2018 is an approximately 57% payout of free cash flow, reinforcing the Company's ongoing commitment to a strong dividend yield.

07:47 EDT Jacobs Engineering awarded contract by Petro Rabigh - Jacobs has received a contract from Rabigh Refining & Petrochemical Company to provide FEED and Project Management Consultancy services on the company's fuel oil upgrade project - Bottom of the Barrel. Located in Rabigh, Saudi Arabia, Bottom of the Barrel is an upgrade project which converts oil residue streams from the crude distillation process into more profitable products. Jacobs is projected to employ 150 full time employees while delivering pre-front end engineering design, FEED and project management over a two-year period.

07:42 EDT Alliance Data's card services business selected by Houzz - Alliance Data's Columbus, Ohio-based card services business has signed a new long-term agreement to provide private label, and co-brand credit card services for Houzz, a platform for home remodeling and design. Alliance Data will provide both private label and co-brand credit card services for Houzz consumers. Additionally, Alliance Data has been selected to provide business credit card services for home professionals on Houzz.

07:41 EDT Lindblad Expeditions orders construction of new polar vessel - Lindblad Expeditions has signed an agreement with Norwegian shipbuilder and ship designer Ulstein to build a new polar vessel, expanding the line's National Geographic polar fleet to four ships. This vessel will be the next phase of Lindblad's fleet expansion following the launches of new builds National Geographic Quest in July 2017, National Geographic Venture in December 2018 and the scheduled delivery of National Geographic Endurance in Q1 2020. The new ship is scheduled for delivery in late Q3 2021.

07:40 EDT Novavax down 68% in pre-market after Prepare trial misses primary endpoint - In pre-market after the report of trial data, Novavax shares are down $1.45, to 68%, to 68c.

07:38 EDT J.C. Penney CEO says company has capacity to deliver improved results - "For the past few months, I have met with and listened to JCPenney associates throughout the organization, as well as our valued suppliers, customers and other partners, to gain their candid perspectives on our Company, both positive and constructive. Based on everything I have seen and heard, I am even more convinced that JCPenney is a revered brand that has the capacity to deliver improved results. In spite of our past financial performance, we have already taken meaningful steps to drive improvement in key businesses such as women's apparel, active apparel, special sized apparel and fine jewelry," said Jill Soltau, CEO of JCPenney. "As we forge a path to sustainable profitable growth, our decisions included eliminating non-core and low gross margin product categories, significantly reducing unproductive inventory and continuing the revitalization of our women's apparel business. While we are pleased with these actions, we know we need to move faster to reestablish the fundamentals of retail, build capabilities focused on satisfying our customers' wants and needs and ensure that our digital and store operations operate seamlessly to provide an experience that wins with customers. We have much work to do to position JCPenney for success and create long-term value for our shareholders, however our unwavering focus and discipline is already enabling meaningful progress," Soltau added.

07:33 EDT Camping World declares cash dividend of 15.32c per share - Camping World Holdings announced that its Board of Directors declared a cash dividend of 15.32c per share on the Company's Class A Common Stock and a cash distribution of 8c per common unit on CWGS Enterprises, LLC's common units. Payment is expected to be made on March 29, 2019, to stockholders of record at the close of business on March 15, 2019. The CWH Class A common stock cash dividend is comprised of a regular quarterly cash dividend of $0.08 per share funded by the 8c per common unit cash distribution by CWGS Enterprises to all holders of its common units, and a 7.32c per share special cash dividend representing a portion of excess tax distributions from CWGS Enterprises.

07:30 EDT Novavax trading resumes

07:22 EDT STAAR Surgical announces strategic cooperation agreement with Vista Oftalmologos - STAAR Surgical announced a Strategic Cooperation Agreement with Vista Oftalmologos, a 49-clinic ophthalmology group spanning Spain, France, Portugal and Morocco with more than 200 eye doctors and 1,000 employees. The agreement positions the EVO Visian ICL family of lenses as a premium and primary refractive procedure for patients suffering from nearsightedness, which is the need for distance vision correction.

07:18 EDT Intercept sees FY19 Ocaliva net sales $225M-$240M - Sees 2019 non-GAAP adjusted operating expenses $450M-$470M, which includes expected resources to support its NASH filing and launch preparation activities.

07:13 EDT Medtronic announces Japanese launch of Grafton DBM bone grafting product - Medtronic announced the Japanese launch of the Grafton Demineralized Bone Matrix bone grafting product for spine and orthopedic procedures. Grafton DBM received PMDA approval in August 2018.

07:04 EDT Medtronic announces approval, lauch of Grafton DBM product in Japan - Medtronic announced the Japanese launch of the Grafton Demineralized Bone Matrix bone grafting product for spine and orthopedic procedures. Grafton DBM is the first and only demineralized bone matrix product available in Japan, the world's second largest market for spinal medical devices. Due to its long clinical history, proven performance, and safety, Grafton DBM received PMDA approval in August 2018. Grafton DBM is a bone graft extender, bone graft substitute, and bone void filler in bony voids or gaps of the skeletal system. With the proprietary D-MIN process, Grafton consistently scores high osteoinductivity, which is an important part of bone fusion The product is commercially available in the U.S., Japan, Korea, Australia, Latin America, the Middle East, and parts of Europe. Grafton is comprised of multiple forms, each with unique handling characteristics. The product forms launching in Japan include Grafton Putty, Grafton Matrix, and Grafton Matrix Strip.

06:59 EDT JD.com up 9% to $28.30 after Q4 profit beats estimates

06:51 EDT Quarterhill subsidiaries enter semiconductor license agreement with SK hynix - Wi-LAN, a Quarterhill company, announced that WiLAN, along with several of its wholly-owned subsidiaries, including Cetus Technologies, have entered into a comprehensive semiconductor license agreement with SK hynix. The licensed patents generally cover dynamic random-access memory, or DRAM, NAND flash memory and other related semiconductor technologies. SK hynix is a South Korean memory semiconductor supplier of DRAM and flash memory chips. The consideration paid by SK hynix and all other terms of the agreement are confidential.

06:37 EDT Toronto-Dominion raises quarterly dividend 10.4% to C$0.74 from C$0.67 - Payable on and after April 30 to shareholders of record at the close of business on April 10.

06:21 EDT Western Union: Sale of Speedpay will not affect FY19 operating margin - Western Union will update its 2019 outlook to reflect the divestiture, including the gain on sale impact to GAAP EPS and the effect from removal of a partial year of Speedpay earnings, as well as any impact from use of proceeds in 2019, in its first quarter earnings release. The company does not expect the divestiture to affect its 2019 operating margin outlook of approximately 20%.

06:15 EDT AB InBev sees 'strong' revenue, EBITDA growth in FY19 - AB InBev says, "In FY19, we expect to deliver strong revenue and EBITDA growth, driven by the solid performance of our brand portfolio and strong commercial plans. Our growth model is even more focused on category expansion, targeting a more balanced top-line growth between volume and revenue per hl. We expect to deliver revenue per hl growth ahead of inflation based on premiumization and revenue management initiatives, while keeping costs below inflation. We expect CoS per hl to increase by mid-single digits, with currency and commodity headwinds to be offset by cost management initiatives. We maintain our 3.2 billion USD synergy and cost savings expectation on a constant currency basis as of August 2016. From this total, 547 million USD was reported by former SAB as of 31 March 2016, and 2 391 million USD was captured between 1 April 2016 and 31 December 2018. The balance of roughly 250 million USD is expected to be captured by the end of 2019. We expect dividends to be a growing flow over time, although growth in the short term is expected to be modest given our deleveraging commitments."

06:06 EDT Western Union announces new $1B share repurchase authorization - The company announced that its Board of Directors approved a new three-year share repurchase authorization. The new $1B share repurchase authorization will expire December 31, 2021 and is in addition to the $544M remaining under the previous authorization as of December 31, 2018.

06:03 EDT DPW Holdings signs $2.5M stock purchase agreement with Ault & Company - DPW Holdings announced it has signed a stock purchase agreement with Ault & Company. The closing of the proposed $2.5M transaction with Ault & Company is subject to approval by the NYSE. Under the terms of the agreement, Ault & Company will invest up to $2.5M in the company through the purchase of the company's series C convertible redeemable preferred stock, during the period ending on December 31. Each share of Preferred Stock par value $0.001, shall be purchased at $1,000 for up to a maximum issuance of 2,500 shares of preferred stock. Each share of preferred stock shall become convertible after eighteen months from the date of issuance into such number of shares of the company's common stock for 12c per share. The preferred stock pays no dividend and is mandatorily redeemable by the company after five years from the date of issuance for the total consideration of up to $2.5M.

06:00 EDT AnaptysBio says cash will fund operating plan at least through end of 2020 - AnaptysBio said it expects that its cash, cash equivalents and investments will fund its current operating plan at least through the end of 2020. The company said, "We continued to advance the clinical development of our wholly-owned etokimab and ANB019 programs for severe inflammatory disease indications during 2018. Top-line data from our etokimab Phase 2a trial in severe adult eosinophilic asthma patients demonstrated rapid and sustained improvement in Forced Exhaled Volume In One Second versus placebo, with corresponding reduction in blood eosinophil levels. We look forward to announcing four Phase 2 top-line data readouts from ongoing clinical trials of etokimab and ANB019 during 2019 and expanding our pipeline with an IND filing for a new wholly-owned anti-inflammatory antibody program."

05:57 EDT Storm Cat Energy announces COO departure, creation of Chief Revenue Officer role - Capital Senior Living announced its COO, Brett Lee, is no longer with the organization, effective immediately. In addition, the company announced that Michael Fryar joined as Chief Revenue Officer, a newly created role. CEO Kimberly Lody said, "In reflecting on the company's operating performance in 2018 and charting a course for 2019 and beyond, we determined that a change in operational leadership is necessary at this time. While we search for a new COO, I will assume this role and lead our operations team. We expect market conditions to remain challenging in 2019, but we are confident that we will make significant progress towards improving the consistency and predictability of our operating results. We recognize the opportunities ahead, and we are focused on building a stronger Capital Senior Living for the benefit of our shareholders and all stakeholders." Fryar, who assumed his role as Chief Revenue Officer on February 25, most recently served as Vice President/North America Marketing for GN Hearing, part of the medical device division of the GN Group.

05:40 EDT Farfetch, JD.com expand strategic partnership - Farfetch (FTCH) and JD.com (JD), China's largest retailer, today announced the expansion of their strategic partnership in order to provide the 'Premier Luxury Gateway to China' for luxury brands. Under the agreement, Toplife will merge into Farfetch China. In addition, Farfetch will gain a 'Level 1' entry point on the JD.com app, providing JD.com's 300 million customers with instant access to more than 3,000 brands via Farfetch's network of more than 1,000 luxury brand and boutique partners. The partnership builds on the existing successful relationship between Farfetch and JD.com, started in July 2017. Since then, Farfetch has leveraged JD.com's logistics capabilities in China, as well as JD.com's insights into the behaviors of China's luxury consumers. JD is one of Farfetch's largest shareholders.

05:18 EDT 3M announces 100% global renewable electricity goal - 3M CEO Mike Roman announced the global manufacturing and technology company is committed to move to 100% renewable electricity in all its facilities around the world, beginning with its own headquarters tomorrow. "3M is flipping the switch to becoming powered 100% by renewable energy," said 3M CEO Mike Roman. "We are continuing to step up our leadership toward a more sustainable future - in our own operations, and in solutions for our customers." 3M becomes the largest company in Xcel Energy Inc's service area across eight Western and Midwestern states to convert to 100 percent renewable electricity. 3M's St. Paul global headquarters is a 409-acre campus with about 12,000 employees across 30 buildings and research labs. 3M's transition to 100 percent renewable electricity at its headquarters will increase the company's total global renewable electricity sourcing by more than 5 percent to approximately 30 percent and further help the company reduce greenhouse gas emissions. 3M has recorded a 68 percent absolute reduction in greenhouse gas emissions since 2002, while nearly doubling its revenue. Committing to 100 percent renewable electricity is part of 3M's strategic focus on science for climate with the aspiration to innovate to decarbonize industry, accelerate global climate solutions and improve the company's environmental footprint. As part of the global goal, 3M is joining RE100, a global leadership initiative, led by The Climate Group in partnership with Carbon Disclosure Project, or CDP, that brings together influential businesses committed to sourcing 100 percent renewable power for their worldwide operations. 3M is committed to the move to sourcing 100 percent of electricity from renewable sources and has set an interim target to source at least 50% of its electricity from renewables by 2025. The majority of the power for 3M's headquarters will be supplied by Xcel wind farms located near Pipestone, Minnesota. Additional electricity will come through the wind projects that are part of Xcel's Windsource program and solar sources.